Article
Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential.
British journal of pharmacology - 1 Mar 2008
Lawrie S M, Hall J, McIntosh A M, Cunningham-Owens D G, Johnstone E C
Abstract excerpt
There is impressive evidence for the involvement of several genetic risk factors in the aetiopathogenesis of schizophrenia. Most of these genes impact on neuropharmacological systems. Examining their relationship with brain imaging indices is arguably the best currently available method of examining these effects in vivo. In a sample of young, initially healthy people at high genetic risk of schizophrenia brain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
